AstraZeneca India plunges; delisting decision delayed
Mar 06 2014 , Mumbai
The board deferred the proposal saying it would seek additional information from its promoter AstraZeneca Pharmaceuticals AB Sweden, which had sought the delisting.
AstraZeneca shares surged 47 percent in the four trading sessions till Tuesday on expectation that the delisting price would be at a substantial premium to the existing market price of the company.
AstraZeneca shares down 7.6 percent at 1,086 rupees as of 11.13 p.m.